Rational Design of Toxoid Vaccine Candidates for Staphylococcus aureus Leukocidin AB (LukAB)
Staphylococcus aureus (SA) infections cause high mortality and morbidity in humans.
Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion
Pleet ML, DeMarino C, Stonier SW, Dye JM, Jacobson S, Aman
Effective Treatment of Staphylococcal Enterotoxin B Aerosol Intoxication in Rhesus Macaques by Using Two Parenterally Administered High-Affinity Monoclonal Antibodies
Verreault D, Ennis J, Whaley K, Killeen SZ, Karauzum H,
Structural basis of broad ebolavirus neutralization by a human survivor antibody
West BR, Wec AZ, Moyer CL, Fusco ML, Ilinykh PA,
TBA225, a fusion toxoid vaccine for protection and broad neutralization of staphylococcal superantigens
Venkatasubramaniam A, Adhikari RP, Kort T, Liao GC, Conley S,
Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primates
Brannan JM, He S, Howell KA, Prugar LI, Zhu W,
Role of Antibodies in Protection Against Ebola Virus in Nonhuman Primates Immunized With Three Vaccine Platforms
Warfield KL, Howell KA, Vu H, Geisbert J, Wong G,
Efficacy of Ebola Glycoprotein-Specific Equine Polyclonal Antibody Product Against Lethal Ebola Virus Infection in Guinea Pigs
Chan M, Holtsberg FW, Vu H, Howell KA, Leung A,
Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles
Pleet ML, Erickson J, DeMarino C, Barclay RA, Cowen M,
Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loop
Janus BM, van Dyk N, Zhao X, Howell KA, Soto
